Clinically Significant Variability of Serum IgE Concentrations in Patients with Severe Asthma

References

• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143–178.
   PubMed Web of Science ®Google Scholar
• Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271–277.
   PubMed Web of Science ®Google Scholar
• Peat JK, Toelle BG, Dermand J, van den Berg R, Britton WJ, Woolcock AJ. Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy 1996; 51:804–810.
   PubMed Web of Science ®Google Scholar
• Sherrill DL, Lebowitz MD, Halonen M, Barbee RA, Burrows B. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med 1995; 152:98–102.
   PubMed Web of Science ®Google Scholar
• Annesi I, Oryszczyn MP, Frette C, Neukirch F, Orvoen-Frija E, Kauffmann F. Total circulating IgE and FEV1 in adult men. An epidemiologic longitudinal study. Chest 1992; 101:642–648.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD; Omalizumab 011 International Study Group. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004; 34:632–638.
   PubMed Web of Science ®Google Scholar
• Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RBJr, Boushey HA. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828–1834.
   PubMed Web of Science ®Google Scholar
• Holgate S, Smith N, Massanari M, Jimenez P. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 2009; 64:1728–1736.
   PubMed Web of Science ®Google Scholar
• Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005; 115:459–465.
   PubMed Web of Science ®Google Scholar
• Buhl R, Hanf G, Solèr M, Bensch G, Wolfe J, Everhard F, Champain K, Fox H, Thirlwell J. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 2002; 20:1088–1094.
   PubMed Web of Science ®Google Scholar
• Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108:184–190.
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma – summary report 2007. J Allergy Clin Immunol 2007; 120:S94–S138.
   PubMed Web of Science ®Google Scholar
• Nickel R, Illi S, Lau S, Sommerfeld C, Bergmann R, Kamin W, Forster J, Schuster A, Niggemann B, Wahn U; German Multicenter Allergy Study Group (MAS-90). Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German Multicenter Allergy Study). Clin Exp Allergy 2005; 35:619–623.
   PubMed Web of Science ®Google Scholar
• Borish L, Chipps B, Deniz Y, Gujrathi S, Zheng B, Dolan CM. TENOR Study Group. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2005; 95:247–253.
   PubMed Web of Science ®Google Scholar
• Gordon EH, Kinney JL, Klaustermeyer WB. The effect of high dose glucocorticoid therapy on immunoglobulin E in asthma. Ann Allergy 1984; 53:476–479.
   PubMedGoogle Scholar
• Posey WC, Nelson HS, Branch B, Pearlman DS. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol 1978; 62:340–348.
   PubMed Web of Science ®Google Scholar
• Zieg G, Lack G, Harbeck RJ, Gelfand EW, Leung DY. In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 1994; 94:222–230.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Hong SJ, Moon HB. Hydrocortisone enhances allergen-specific IgE production by peripheral blood mononuclear cells from atopic patients with high serum allergen-specific IgE levels. Clin Exp Allergy 2000; 30:1576–1581.
   PubMed Web of Science ®Google Scholar
• Fennerty AG, Jones KP, Davies BH, Fifield R, Edwards J. Immunological changes associated with a successful outcome of pollen immunotherapy. Allergy 1988; 43:415–419.
   PubMed Web of Science ®Google Scholar
• Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, Ebner H, Ebner C. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 120:218–224.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, Pauli G, Caillaud D, Dubost R, Leynadier F, Vervloet D, Herman D, Galvain S, André C. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999; 54:249–260.
   PubMed Web of Science ®Google Scholar
• Birkner T, Rumpold H, Jarolim E, Ebner H, Breitenbach M, Skvaril F, Scheiner O, Kraft D. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990; 45:418–426.
   Google Scholar
• Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27:1007–1015.
   PubMed Web of Science ®Google Scholar
• Creticos PS, Van Metre TE, Mardiney MR, Rosenberg GL, Norman PS, Adkinson NFJr. Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 1984; 73:94–104.
   PubMed Web of Science ®Google Scholar
• Beeh KM, Beier J, Buhl R. Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE). Pneumologie 2004; 58:546–551.
   PubMedGoogle Scholar